Two Sigma Advisers
BPMC

Two Sigma Advisers’s Blueprint Medicines BPMC Stock Holding History

Two Sigma Advisers’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-47,200
Closed -$2.12M – 2401
2023
Q1 		$2.12M Sell
47,200
-28,700
-38% -$1.29M 0.01% 1247
2022
Q4 		$3.33M Buy
75,900
+14,000
+23% +$671K 0.01% 956
2022
Q3 		$4.08M Buy
+61,900
New +$3.98M 0.01% 836
2020
Q1 		– Sell
-73,600
Closed -$5.9M – 2466
2019
Q4 		$5.9M Sell
73,600
-43,500
-37% -$3.26M 0.01% 787
2019
Q3 		$8.6M Buy
117,100
+2,900
+3% +$251K 0.02% 593
2019
Q2 		$10.8M Sell
114,200
-2,200
-2% -$182K 0.03% 562
2019
Q1 		$9.32M Sell
116,400
-42,900
-27% -$3.17M 0.02% 629
2018
Q4 		$8.59M Sell
159,300
-2,300
-1% -$140K 0.02% 611
2018
Q3 		$12.6M Sell
161,600
-65,400
-29% -$4.55M 0.03% 517
2018
Q2 		$14.4M Buy
227,000
+151,800
+202% +$12.1M 0.04% 474
2018
Q1 		$6.9M Sell
75,200
-6,200
-8% -$534K 0.02% 725
2017
Q4 		$6.14M Buy
81,400
+38,400
+89% +$2.7M 0.02% 780
2017
Q3 		$3M Buy
43,000
+33,100
+334% +$1.77M 0.01% 1014
2017
Q2 		$502K Sell
9,900
-1,500
-13% -$63.7K ﹤0.01% 1799
2017
Q1 		$456K Buy
+11,400
New +$408K ﹤0.01% 1933

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Two Sigma Advisers's BPMC Position: Q2 2023 in Review

Two Sigma Advisers sold out of Blueprint Medicines (BPMC) in Q2 2023, closing a stake of 47,200 shares — an estimated $2.12M sold.

Two Sigma Advisers first reported a position in BPMC in Q1 2017 and held it in 15 quarters. The position peaked at $14.4M in Q2 2018. 222 funds tracked by Wall St. Rank hold BPMC as of Q2 2023.

  • Two Sigma Advisers reported no remaining Blueprint Medicines position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 47,200 Blueprint Medicines shares in Q2 2023, an estimated $2.12M.
  • Two Sigma Advisers first reported a position in Blueprint Medicines in Q1 2017 and held it in 15 quarters.
  • Two Sigma Advisers's Blueprint Medicines position peaked at $14.4M in Q2 2018.
  • 222 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2023.

Based on Two Sigma Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.